Andrew G. Sikora, M.D., Ph.D., Clinical Team Leader Baylor College of Medicine

Translating the power of Immunotherapy into new cancer treatments.
Area of Research: Head and Neck Cancer

Dr. Sikora, along with Sacha Gnjatic, Ph.D., Christine Chung, M.D., and Nham Tran, Ph.D., are working to improve the immune-stimulating effects of chemo-radiotherapy (CRT) in HPV-associated head and neck cancer, by targeting the tumor microenvironment (TME). Part of their work involves analyzing tumors and peripheral blood samples from patients before and during CRT and determining its effects on circulating antibodies. They’re also using mouse models of HPV-associated head and neck cancer to test different CRT dosing regimens and determine how combining CRT with an NOS (nitric oxide synthase) inhibitor as well as a genetically engineered bacteria expressing an HPV antigen influences anti-tumor responses.

Projects and Grants

Targeting the tumor immune microenvironment to enhance immune-stimulating effects of chemoradiotherapy

Baylor College of Medicine | Head and Neck Cancer | 2015

Let's spread the word about Immunotherapy! Click to share this page with your community.

*Immunotherapy results may vary from patient to patient.